ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

ALLK Allakos Inc

1,10
-0,03 (-2,65%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Allakos Inc ALLK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,03 -2,65% 1,10 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,17 1,08 1,17 1,10 1,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.3.202421:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
07.3.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:22EDGAR2Form 144 - Report of proposed sale of securities
04.3.202423:52EDGAR2Form 144 - Report of proposed sale of securities
26.2.202413:05EDGAR2Form 8-K - Current report
26.2.202413:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
21.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202401:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.2.202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202414:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202413:07EDGAR2Form 8-K - Current report
12.2.202413:02GLOBEAllakos Announces Publication Highlighting AK006 Mast Cell..
02.2.202422:05EDGAR2Form 8-K - Current report
02.2.202418:31EDGAR2Form SC 13D/A - General statement of acquisition of..
16.1.202423:00EDGAR2Form 8-K - Current report
16.1.202413:02GLOBEAllakos Announces a Restructuring to Focus on Development of..
16.1.202413:00GLOBEAllakos Announces Phase 2 Lirentelimab Trials in Atopic..
05.1.202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
06.12.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202321:49EDGAR2Form 144 - Report of proposed sale of securities
04.12.202321:31EDGAR2Form 144 - Report of proposed sale of securities
04.12.202321:21EDGAR2Form 144 - Report of proposed sale of securities
27.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13.11.202323:01EDGAR2Form S-3 - Registration statement under Securities Act of..
13.11.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:10EDGAR2Form 8-K - Current report
13.11.202322:02GLOBEAllakos Provides Business Update and Reports Third Quarter..
07.9.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202322:06EDGAR2Form 144 - Report of proposed sale of securities
05.9.202321:57EDGAR2Form 144 - Report of proposed sale of securities
05.9.202321:52EDGAR2Form 144 - Report of proposed sale of securities
30.8.202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.8.202322:05EDGAR2Form 8-K - Current report
30.8.202322:05GLOBEAllakos Appoints Neil Graham to its Board of Directors
21.8.202322:02EDGAR2Form 8-K - Current report
09.8.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:08EDGAR2Form 8-K - Current report
09.8.202322:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
04.8.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.8.202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:05GLOBEAllakos Appoints Rand Sutherland and Dolca Thomas to its..
02.8.202322:03EDGAR2Form 8-K - Current report
12.6.202313:02GLOBEAllakos Presents Preclinical Data at EAACI Hybrid Congress..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock